Welcome to our dedicated page for Reneo Pharmaceuticals SEC filings (Ticker: RPHM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reneo Pharmaceuticals Inc. filings document the registrant's public-company reporting after a corporate transition reflected in later filings as OnKure Therapeutics, Inc. The filing record includes Form 8-K disclosures for quarterly financial results, Regulation FD corporate presentations and related exhibit materials.
The disclosures provide formal records of operating results, furnished investor communications and corporate-status context for a registrant whose earlier public identity was tied to pharmaceutical development for rare genetic mitochondrial diseases.